Pain News and Research

Latest Pain News and Research

Spinal cord meninges is a potential source of self-renewing stem cells

Italian and Spanish scientists studying the use of stem cells for treating spinal cord injuries have provided the first evidence to show that meninges, the membrane which envelops the central nervous system, is a potential source of self-renewing stem cells.

28 Oct 2011

First-ever study of chronic postoperative pain in children

Are children suffering needlessly after surgery? UC Irvine anesthesiologists who specialize in pediatric care believe so. An operation can be one of the most traumatic events children face, and according to a UCI study, many of them experience unnecessary postsurgical pain lasting weeks or months.

28 Oct 2011

CINJ experts available to discuss risk factors of pancreatic cancer

According to the American Cancer Society, pancreatic cancer is the fifth leading cancer killer in the country, with nearly 44,000 new cases expected in 2011 and more than 37,600 deaths by year's end. In New Jersey alone, an estimated 1,100 deaths are predicted this year due to the disease. The death of Steve Jobs, who suffered from a form of pancreatic cancer, has brought increased attention to the disease in recent weeks.

28 Oct 2011

FDA's advisory panel votes against approval of Medtronic Phased RF Ablation System

Medtronic, Inc. today announced that the U.S. Food and Drug Administration's (FDA) Circulatory Systems Devices advisory panel voted against the Medtronic Phased RF Ablation System, the first atrial fibrillation ablation therapy under investigation for the treatment of persistent and long-standing persistent atrial fibrillation.

28 Oct 2011

Regeneron announces positive results from sarilumab Phase 2b trial on RA

Regeneron Pharmaceuticals, Inc. today announced that detailed clinical data from the positive Phase 2b portion of the seamless Phase 2/3 MOBILITY trial of sarilumab in rheumatoid arthritis (RA) will be presented at a late-breaking poster session at the upcoming American College of Rheumatology (ACR) Annual Scientific Meeting, which will take place from November 5-9 in Chicago.

28 Oct 2011

Mylan receives final FDA approval for Morphine Sulfate ER Tablets ANDA

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Morphine Sulfate Extended-release (ER) Tablets, 15 mg, 30 mg, 60 mg, 100 mg and 200 mg, the generic version of Purdue Pharma's MS Contin, an opioid analgesic for moderate to severe pain management.

27 Oct 2011

Medtronic initiates Symplicity System clinical study in treatment-resistant hypertension

Medtronic Inc. announced today the start of SYMPLICITY HTN-3, the company's U.S. clinical trial of the Symplicity Renal Denervation System for treatment-resistant hypertension.

From Medtronic 27 Oct 2011

Nanoparticles could help increase retention of osteoarthritis drugs in knee cavity

A novel study demonstrates that using nanoparticles to deliver osteoarthritis drugs to the knee joint could help increase the retention of the drug in the knee cavity, and therefore reduce the frequency of injections patients must receive.

27 Oct 2011

EC approves Pfizer's pneumococcal conjugate vaccine, Prevenar 13

Pfizer Inc. announced today that the European Commission has approved the Company's pneumococcal conjugate vaccine, Prevenar 13 (pneumococcal polysaccharide conjugate vaccine, for active immunization for the prevention of vaccine-type invasive disease caused by Streptococcus pneumoniae in adults aged 50 years and older.

27 Oct 2011

Gilead, Bristol-Myers Squibb to develop and commercialize fixed-dose combination for HIV

Bristol-Myers Squibb Company and Gilead Sciences, Inc. today announced a licensing agreement for Bristol-Myers Squibb to develop and commercialize a fixed-dose combination containing Bristol-Myers Squibb's protease inhibitor REYATAZ (atazanavir sulfate) and Gilead's cobicistat, a pharmacoenhancing or "boosting" agent that increases blood levels of certain HIV medicines to potentially allow for one pill once daily dosing.

27 Oct 2011

Bacterin reports results of two-year study for OsteoSponge

Bacterin International Holdings, Inc., a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, reported results of a two-year study for OsteoSponge.

27 Oct 2011

Taking the Pill for 10 years can reduce risk of ovarian cancer by almost half

Taking the Pill for 10 years can reduce the risk of ovarian cancer by almost half (45 per cent), new research part-funded by Cancer Research UK shows today.

27 Oct 2011

Yoga for low back pain as effective as stretching exercises: Study

Study shows that weekly yoga classes eased pain and improved functioning in some people with chronic lower back pain. However the effects of yoga were not much different from usual stretching exercises.

25 Oct 2011

Your medical privacy – Another Obamacare casualty

It was a sad day recently when a married menopausal woman learned that her recent Pap test was positive for human papilloma virus (HPV). “How could this happen?” she asked. “I have not had relations with anyone but my husband since we married 30 years ago.”

24 Oct 2011

CompCare to distribute innovative lumbar traction DDS belt in the U.S., Canada and Puerto Rico

Comprehensive Care Corporation, which provides behavioral health, substance abuse and psychotropic pharmacy management services for managed care companies throughout the U.S., today announced that it has acquired exclusive distribution rights to an innovative patented product aimed directly at reducing depression in individuals resulting from chronic back pain.

24 Oct 2011

Blood tests and cultures may not be necessary in detecting early-onset GBS in newborns

For newborn infants at risk of infection with group B streptococcal (GBS) bacteria, screening blood tests cause extra pain and anxiety—without increasing detection of early-onset GBS disease, reports a study in the October issue of The Pediatric Infectious Disease Journal. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

24 Oct 2011

Exploring palliative care's positives and negatives

What if a new medication for severely ill patients had no role in curing them but made them feel much better despite being sick?

24 Oct 2011

Lundbeck's ONFI receives FDA approval for treating seizures associated with Lennox-Gastaut syndrome

Lundbeck Inc., a wholly owned subsidiary of H. Lundbeck A/S in Denmark, announced today that the U.S. Food and Drug Administration (FDA) has approved ONFI as adjunctive therapy for seizures associated with Lennox-Gastaut syndrome in patients two years and older.

24 Oct 2011

Zynex ranked 127th on Deloitte's 2011 Technology Fast 500 list

Zynex, Inc., a provider and developer of non-invasive medical devices for electrotherapy and stroke rehabilitation, neurological diagnosis and cardiac monitoring, announced that it has been ranked 127th on Deloitte's 2011 Technology Fast 500 list for revenue growth between 2006 and 2010.

24 Oct 2011

Vertex initiates INCIVEK combination Phase 3b study for hepatitis C

Vertex Pharmaceuticals Incorporated today announced the initiation of a Phase 3b study called CONCISE that will evaluate the potential for treatment with INCIVEK (telaprevir) combination therapy to be shortened to 12 weeks in people with genotype 1 chronic hepatitis C who have the 'CC' variation near the IL28B gene.

24 Oct 2011

Pain News and Research

Latest Pain News and Research

Spinal cord meninges is a potential source of self-renewing stem cells

First-ever study of chronic postoperative pain in children

CINJ experts available to discuss risk factors of pancreatic cancer

FDA's advisory panel votes against approval of Medtronic Phased RF Ablation System

Regeneron announces positive results from sarilumab Phase 2b trial on RA

Mylan receives final FDA approval for Morphine Sulfate ER Tablets ANDA

Medtronic initiates Symplicity System clinical study in treatment-resistant hypertension

Nanoparticles could help increase retention of osteoarthritis drugs in knee cavity

EC approves Pfizer's pneumococcal conjugate vaccine, Prevenar 13

Gilead, Bristol-Myers Squibb to develop and commercialize fixed-dose combination for HIV

Bacterin reports results of two-year study for OsteoSponge

Taking the Pill for 10 years can reduce risk of ovarian cancer by almost half

Yoga for low back pain as effective as stretching exercises: Study

Your medical privacy – Another Obamacare casualty

CompCare to distribute innovative lumbar traction DDS belt in the U.S., Canada and Puerto Rico

Blood tests and cultures may not be necessary in detecting early-onset GBS in newborns

Exploring palliative care's positives and negatives

Lundbeck's ONFI receives FDA approval for treating seizures associated with Lennox-Gastaut syndrome

Zynex ranked 127th on Deloitte's 2011 Technology Fast 500 list

Vertex initiates INCIVEK combination Phase 3b study for hepatitis C

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Pain News and Research

Latest Pain News and Research

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in